Product Information |
|
Registration Number |
DRP-12424-03
|
Generic Name |
Omeprazole (as sodium monohydrate)
|
Brand Name |
Omepace
|
Dosage Strength |
40 mg
|
Dosage Form |
Lyophilized Powder for Injection (I.V.)
|
Classification |
Prescription Drug (Rx)
|
Pharmacologic Category |
Proton Pump Inhibitor
|
Packaging |
10 mL amber and transparent USP Type II glass tubular vials sealed with gray butyl rubber stopper and blue aluminum plastic cap + 10 mL USP Type I glass transparent colorless ampoule (Water for Injection as diluent) / (Box of 1's)
|
Manufacturer |
Reyoung Pharmaceutical Co., Ltd.
|
Country of Origin |
China
|
Trader |
|
Importer |
GPC Geo Pharma Corporation
|
Distributor |
QLap Endoscopics Inc.
|
Application Type |
CLIDP Conversion
|
Issuance Date |
17 March 2024
|
Expiry Date |
04 August 2027
|